We assign a technical rating of 0 out of 10 to AQB. AQB scores bad on all fronts: it is a bad performer in the overall market and both the medium and short term pictures are negative.
The short term trend is neutral, while the long term trend is still negative. We need to see a little more continued positive action to make this really interesting.
89% of all other stocks performed better in the past year than AQB.
AQB is currently trading in the lower part of its 52 week range, which is not a good signal. Agreed, the S&P500 Index is also not doing fantastic, but it still sitting in the middle of its 52 week range.
In the last month AQB has a been trading in the 0.61 - 0.72 range, which is quite wide. It is currently trading in the middle of this range where prices have been consolidating recently, this may present a good entry opportunity, but some resistance may be present above.
AQB has an average volume of 1205370 traded shares per day. This is a good sign as it is always nice to have a liquid stock.
AQB is an average performer in the Biotechnology industry, it outperforms 45% of 566 stocks in the same industry.
Considerably lower volume is observed in the last couple of days.